Dr. Frank Moskos, M.D

NPI: 1356543193
Total Payments
$2,733
2024 Payments
$414.98
Companies
24
Transactions
183
Medicare Patients
1,546
Medicare Billing
$105,576

Payment Breakdown by Category

Food & Beverage$2,724 (99.7%)
Education$8.74 (0.3%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $2,724 182 99.7%
Education $8.74 1 0.3%

Top Paying Companies

Company Total Records Latest Year
Novartis Pharmaceuticals Corporation $623.13 40 $0 (2024)
PFIZER INC. $569.81 44 $0 (2024)
Novo Nordisk Inc $315.47 23 $0 (2024)
SANOFI-AVENTIS U.S. LLC $297.36 12 $0 (2024)
Janssen Pharmaceuticals, Inc $163.10 12 $0 (2023)
AstraZeneca Pharmaceuticals LP $123.71 9 $0 (2021)
GlaxoSmithKline, LLC. $100.31 7 $0 (2023)
E.R. Squibb & Sons, L.L.C. $87.27 6 $0 (2022)
Allergan Inc. $76.17 6 $0 (2019)
ABBVIE INC. $61.53 4 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $414.98 23 Novartis Pharmaceuticals Corporation ($175.61)
2023 $352.37 26 Novartis Pharmaceuticals Corporation ($145.49)
2022 $215.55 15 PFIZER INC. ($86.90)
2021 $196.46 14 Novo Nordisk Inc ($66.43)
2020 $132.64 9 Novo Nordisk Inc ($34.82)
2019 $245.87 16 Novartis Pharmaceuticals Corporation ($132.57)
2018 $198.77 15 Allergan Inc. ($48.31)
2017 $976.33 65 PFIZER INC. ($288.66)

All Payment Transactions

183 individual payment records from CMS Open Payments — Page 1 of 8

Date Company Product Nature Form Amount Type
12/16/2024 Novartis Pharmaceuticals Corporation LEQVIO (Drug) Food and Beverage In-kind items and services $23.03 General
Category: Cardiology/Vascular Diseases
11/20/2024 SCPHARMACEUTICALS INC. FUROSCIX (Drug) Food and Beverage In-kind items and services $17.82 General
Category: Cardiology
11/12/2024 Novo Nordisk Inc Rybelsus (Drug), Ozempic Food and Beverage In-kind items and services $19.50 General
Category: Diabetes
10/04/2024 VERTEX PHARMACEUTICALS INCORPORATED Food and Beverage In-kind items and services $17.54 General
09/19/2024 Novartis Pharmaceuticals Corporation LEQVIO (Drug) Food and Beverage In-kind items and services $24.41 General
Category: Cardiology/Vascular Diseases
08/15/2024 Novo Nordisk Inc Food and Beverage In-kind items and services $18.46 General
08/13/2024 Novartis Pharmaceuticals Corporation LEQVIO (Drug) Food and Beverage In-kind items and services $23.19 General
Category: Cardiology/Vascular Diseases
07/30/2024 PFIZER INC. ELIQUIS (Drug), PAXLOVID, NURTEC ODT Food and Beverage In-kind items and services $16.42 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
07/25/2024 Novo Nordisk Inc Ozempic (Drug), Rybelsus Food and Beverage In-kind items and services $17.32 General
Category: Diabetes
07/21/2024 CVRx, Inc. Barostim Neo System (Device) Food and Beverage Cash or cash equivalent $14.06 General
Category: Heart Failure and Hypertension
07/16/2024 Novartis Pharmaceuticals Corporation ENTRESTO (Drug), LEQVIO Food and Beverage In-kind items and services $19.69 General
Category: Cardiology/Vascular Diseases
06/18/2024 Novartis Pharmaceuticals Corporation ENTRESTO (Drug), LEQVIO Food and Beverage In-kind items and services $15.61 General
Category: Cardiology/Vascular Diseases
05/28/2024 Novartis Pharmaceuticals Corporation ENTRESTO (Drug), LEQVIO Food and Beverage In-kind items and services $11.29 General
Category: Cardiology/Vascular Diseases
05/13/2024 CVRx, Inc. Barostim Neo System (Device) Food and Beverage Cash or cash equivalent $11.18 General
Category: Heart Failure and Hypertension
04/29/2024 Novo Nordisk Inc Rybelsus (Drug), Ozempic Food and Beverage In-kind items and services $14.78 General
Category: Diabetes
04/09/2024 Novartis Pharmaceuticals Corporation ENTRESTO (Drug), LEQVIO Food and Beverage In-kind items and services $14.02 General
Category: Cardiology/Vascular Diseases
03/12/2024 Novartis Pharmaceuticals Corporation LEQVIO (Drug), ENTRESTO Food and Beverage In-kind items and services $13.17 General
Category: Cardiology/Vascular Diseases
03/08/2024 ABBVIE INC. QULIPTA (Drug), UBRELVY Food and Beverage In-kind items and services $13.87 General
Category: NEUROSCIENCE
03/05/2024 SANOFI-AVENTIS U.S. LLC TZIELD (Biological) Food and Beverage In-kind items and services $42.45 General
Category: Endocrine & Metabolic Diseases
02/20/2024 Novartis Pharmaceuticals Corporation ENTRESTO (Drug), LEQVIO Food and Beverage In-kind items and services $15.28 General
Category: Cardiology/Vascular Diseases
02/01/2024 Novo Nordisk Inc Food and Beverage In-kind items and services $19.37 General
01/25/2024 PFIZER INC. ELIQUIS (Drug), PAXLOVID, NURTEC ODT Food and Beverage In-kind items and services $16.60 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
01/23/2024 Novartis Pharmaceuticals Corporation LEQVIO (Drug), ENTRESTO Food and Beverage In-kind items and services $15.92 General
Category: Cardiology/Vascular Diseases
12/26/2023 Lilly USA, LLC JARDIANCE (Drug) Food and Beverage In-kind items and services $13.80 General
Category: Diabetes
12/11/2023 Novartis Pharmaceuticals Corporation LEQVIO (Drug), ENTRESTO Food and Beverage In-kind items and services $15.30 General
Category: Cardiology/Vascular Diseases

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 7 426 630 $121,326 $32,753
2022 8 363 491 $91,058 $24,779
2021 8 377 499 $93,507 $26,955
2020 8 380 497 $81,125 $21,089
Total Patients
1,546
Total Services
2,117
Medicare Billing
$105,576
Procedure Codes
31

All Medicare Procedures & Services

31 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99231 Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes Facility 2023 81 182 $29,114 $6,527 22.4%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 38 101 $17,339 $5,865 33.8%
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes Facility 2023 57 61 $20,141 $5,537 27.5%
99213 Established patient office or other outpatient visit, 20-29 minutes Facility 2023 97 120 $18,380 $5,328 29.0%
99238 Hospital discharge day management, 30 minutes or less Facility 2023 80 84 $18,175 $4,880 26.8%
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2023 55 64 $14,002 $3,553 25.4%
99221 Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes Facility 2023 18 18 $4,175 $1,063 25.5%
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2022 87 107 $23,326 $6,220 26.7%
99219 Initial hospital observation care per day, typically 50 minutes Facility 2022 40 40 $12,854 $4,083 31.8%
99213 Established patient office or other outpatient visit, 20-29 minutes Facility 2022 75 90 $13,680 $4,002 29.3%
99231 Follow-up hospital inpatient care per day, typically 15 minutes Facility 2022 53 116 $16,902 $3,450 20.4%
99232 Follow-up hospital inpatient care per day, typically 25 minutes Facility 2022 33 61 $10,215 $3,351 32.8%
99238 Hospital discharge day management, 30 minutes or less Facility 2022 37 38 $7,990 $2,097 26.2%
99217 Hospital observation care on day of discharge Facility 2022 20 20 $4,210 $1,100 26.1%
99212 Established patient office or other outpatient visit, 10-19 minutes Facility 2022 18 19 $1,881 $476.97 25.4%
99214 Established patient outpatient visit, total time 30-39 minutes Facility 2021 138 177 $38,586 $10,272 26.6%
99213 Established patient outpatient visit, total time 20-29 minutes Facility 2021 77 91 $13,832 $4,101 29.6%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2021 37 62 $10,142 $3,450 34.0%
99219 Hospital observation care, typically 50 minutes Facility 2021 28 28 $8,820 $2,910 33.0%
99231 Subsequent hospital inpatient care, typically 15 minutes per day Facility 2021 34 77 $8,497 $2,293 27.0%
99222 Initial hospital inpatient care, typically 50 minutes per day Facility 2021 18 19 $5,980 $1,998 33.4%
99238 Hospital discharge day management, 30 minutes or less Facility 2021 30 30 $6,165 $1,670 27.1%
99212 Established patient outpatient visit, total time 10-19 minutes Facility 2021 15 15 $1,485 $262.71 17.7%
99213 Established patient office or other outpatient visit, typically 15 minutes Facility 2020 171 219 $33,288 $7,276 21.9%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2020 28 63 $10,269 $3,580 34.9%

About Dr. Frank Moskos, M.D

Dr. Frank Moskos, M.D is a Family Medicine healthcare provider based in Florence, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/04/2007. The National Provider Identifier (NPI) number assigned to this provider is 1356543193.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Frank Moskos, M.D has received a total of $2,733 in payments from pharmaceutical and medical device companies, with $414.98 received in 2024. These payments were reported across 183 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($2,724).

As a Medicare-enrolled provider, Moskos has provided services to 1,546 Medicare beneficiaries, totaling 2,117 services with total Medicare billing of $105,576. Data is available for 4 years (2020–2023), covering 31 distinct procedure/service records.

Practice Information

  • Specialty Family Medicine
  • Location Florence, SC
  • Active Since 06/04/2007
  • Last Updated 10/27/2023
  • Taxonomy Code 207Q00000X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1356543193

Products in Payments

  • ENTRESTO (Drug) $418.77
  • ELIQUIS (Drug) $320.29
  • LEQVIO (Drug) $185.75
  • EUCRISA (Drug) $175.52
  • XARELTO (Drug) $163.10
  • Ozempic (Drug) $158.28
  • SOLIQUA (Drug) $144.59
  • TOUJEO (Drug) $90.24
  • LYRICA (Drug) $54.04
  • TEFLARO (Drug) $51.49
  • Rybelsus (Drug) $48.86
  • FARXIGA (Drug) $47.29
  • ANORO (Drug) $45.89
  • TZIELD (Biological) $42.45
  • Victoza (Drug) $34.02
  • JARDIANCE (Drug) $26.15
  • BREO (Drug) $25.26
  • Barostim Neo System (Device) $25.24
  • DALVANCE (Drug) $24.68
  • BEVESPI AEROSPHERE (Drug) $24.62

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Family Medicine Doctors in Florence